Skip to content
[P]pubcas
Independent chemical reference Compare
Chemical substance record

Ritlecitinib

1792180-81-4C15H19N5O285.351 g/mol

A pyrrolopyrimidine that is 7H-pyrrolo[2,3-d]pyrimidine substituted at position 4 by a [(3R,6S)-6-methyl-1-(prop-2-enoyl)piperidin-3-yl]amino group. It is a dual inhibitor of Janus kinase 3 and the TEC family of tyrosine kinases. — ChEBI

Safety references

Safety documents & references

Supplier matching matters

Find the safety document for your specific supplier, product number and grade.

Find a product-specific SDS

Safety guides and government classification records are not a manufacturer’s SDS. Match supplier, product number, concentration, physical form, region and revision before using a document.

Identity & molecular properties

Source-linked values
CAS number1792180-81-4ChEBI ↗
Molecular formulaC15H19N5OChEBI ↗
Molar mass285.351 g/molChEBI ↗
Monoisotopic mass285.15896 DaChEBI ↗
Formal charge0ChEBI ↗
ChEBI identifierCHEBI:229233ChEBI ↗

Cross-source molecular data

PubChem
Molar mass285.34 g/molPubChem ↗
Exact mass285.15896025 DaPubChem ↗
Computed XLogP2.1PubChem ↗
Topological polar surface area (Ų)73.9PubChem ↗
H-bond donors2PubChem ↗
H-bond acceptors4PubChem ↗
Rotatable bonds3PubChem ↗

PubChem computed values are shown separately from the ChEBI record. An exact InChIKey match was used to connect the records. Molecular descriptors do not describe a supplied product’s purity, particle size or performance.

Names & structural identifiers

Copy any identifier
ritlecitinib
1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)piperidin-1-yl]prop-2-en-1-one
CBRJPFGIXUFMTM-WDEREUQCSA-N
C=CC(=O)N1C[C@H](Nc2ncnc3nccc23)CC[C@@H]1C
InChI=1S/C15H19N5O/c1-3-13(21)20-8-11(5-4-10(20)2)19-15-12-6-7-16-14(12)17-9-18-15/h3,6-7,9-11H,1,4-5,8H2,2H3,(H2,16,17,18,19)/t10-,11+/m0/s1

Names & synonyms

1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)piperidin-1-yl]prop-2-en-1-oneritlecitinibum

Names are supplied by ChEBI. Trade names and related synonyms may describe a broader product context.

Classification & relationships

ChEBI ontology

Roles recorded in ChEBI

renoprotective agentanti-inflammatory drughypoglycemic agentantineoplastic agentimmunosuppressive agentantirheumatic drugdermatologic druganti-inflammatory agentEC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor

Database role annotations describe reported biological or chemical roles; they are not product approvals or recommendations for use.

Mass ↔ amount of substance

Calculated from sourced mass
Equivalent amount
0.00350446 mol

Uses 285.351 g/mol from ChEBI. Assumes the substance described by this record; no purity or concentration correction is applied.

Elemental composition

Theoretical mass fractions
C
Carbon · 15 atoms
63.14%
N
Nitrogen · 5 atoms
24.54%
H
Hydrogen · 19 atoms
6.71%
O
Oxygen · 1 atom
5.61%

Calculated theoretical mass fractions from the reported formula and PubChem periodic-table atomic masses. These are not assay or purity results.

Research & patent references

Selected source associations

Sources & record history

Checked 27 Sep 2026
EMBL-EBI ChEBI · CHEBI:229233

Release 255, 9 September 2026. ChEBI three-star (manually annotated) source entry. View original record ↗ · CC BY 4.0

NCBI PubChem · CID 118115473 · retrieved 2026-09-27

PubCAS formats source data, connects references and computes explicitly labelled conversions. CAS cross-references are supplied by ChEBI; they do not constitute CAS verification or endorsement.